{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:29:48Z","timestamp":1773923388181,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.diagmicrobio.2005.02.006","type":"journal-article","created":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T11:20:07Z","timestamp":1117106407000},"page":"235-246","source":"Crossref","is-referenced-by-count":23,"title":["Reevaluation of Enterobacteriaceae MIC\/disk diffusion zone diameter regression scattergrams for 9 \u03b2-lactams: adjustments of breakpoints for strains producing extended spectrum \u03b2-lactamases"],"prefix":"10.1016","volume":"52","author":[{"given":"Ronald N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael N.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Pottumarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib1","article-title":"Use of pharmacokinetic-pharmacodynamic and Monte-Carlo simulation as decision support for the re-evaluation of NCCLS cephem susceptibility breakpoints for Enterobacteriaceae","author":"Ambrose","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.22.5.859","article-title":"Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, \u03b2-lactamase stability, a preliminary recommendations for disk diffusion testing","volume":"22","author":"Ayers","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib3","article-title":"Evaluation of patients with ESBL- and non-ESBL-producing Enterobacteriaceae: outcomes report from the SENTRY Antimicrobial Surveillance Program","author":"Bhavnani","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1086\/319610","article-title":"New \u03b2-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy","volume":"32","author":"Bush","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib6","first-page":"1167","article-title":"Laboratory capacity to detect antimicrobial resistance, 1998","volume":"48","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diagmicrobio.2004.07.006","article-title":"The inoculum effect: fact, or artifact?","volume":"50","author":"Craig","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib8","article-title":"Impact of ESBLs on in vivo activity of four cephalosporins in the neutropenic mouse-thigh infection model","author":"Craig","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.18.1.88","article-title":"Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing","volume":"18","author":"Fuchs","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/JCM.23.3.634-636.1986","article-title":"Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin","volume":"23","author":"Fuchs","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.39.5.1187","article-title":"In vitro activities of various \u03b2-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins","volume":"39","author":"Jett","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib12","article-title":"Experience with ESBL-producing Enterobacteriaceae treated with carbapenems compared to other \u03b2-lactams: outcome report from SENTRY Antimicrobial Surveillance Program","author":"Jones","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/dkg312","article-title":"European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria","volume":"52","author":"Kahlmeter","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib13","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream infections by extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/AAC.48.6.1941-1947.2004","article-title":"Determination of the in-vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula","volume":"48","author":"Maglio","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib15","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/clinids\/24.Supplement_1.S19","article-title":"Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics","volume":"24","author":"Medeiros","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib16","series-title":"Approved standard M23-A2","article-title":"Development of in vitro susceptibility testing criteria and quality control parameters","author":"National Committee for Clinical Laboratory Standards","year":"2001"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib17","series-title":"Approved standard M7-A6","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib18","series-title":"Approved standard M2-A8","article-title":"Methods for antimicrobial disk susceptibility tests","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib19","series-title":"14th Informational supplement M100-S15","article-title":"Performance standards for antimicrobial susceptibility testing","author":"National Committee for Clinical Laboratory Standards","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib20","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3201\/eid0702.010238","article-title":"Controversies about extended-spectrum and AmpC beta-lactamases","volume":"7","author":"Thomson","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.02.006_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T12:15:41Z","timestamp":1586261741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889305000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0732889305000349"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.02.006","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}